3.24
Orasure Technologies Inc stock is traded at $3.24, with a volume of 223.87K.
It is up +0.93% in the last 24 hours and up +9.09% over the past month.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
See More
Previous Close:
$3.21
Open:
$3.2
24h Volume:
223.87K
Relative Volume:
0.46
Market Cap:
$223.97M
Revenue:
$115.02M
Net Income/Loss:
$-68.73M
P/E Ratio:
-3.4626
EPS:
-0.9357
Net Cash Flow:
$-53.22M
1W Performance:
+5.19%
1M Performance:
+9.09%
6M Performance:
+5.88%
1Y Performance:
+10.58%
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OSUR
Orasure Technologies Inc
|
3.24 | 221.90M | 115.02M | -68.73M | -53.22M | -0.9357 |
|
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Resumed | Evercore ISI | In-line |
| Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-21-20 | Initiated | Evercore ISI | Outperform |
| Aug-10-20 | Initiated | Citigroup | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
| Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-25-20 | Initiated | Lake Street | Buy |
| Apr-21-20 | Resumed | Stephens | Equal-Weight |
| Oct-23-18 | Resumed | Raymond James | Mkt Perform |
| Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-05-15 | Reiterated | Mizuho | Buy |
| May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-23-15 | Reiterated | Mizuho | Buy |
| Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
| Jun-11-14 | Reiterated | Mizuho | Buy |
| Dec-21-12 | Initiated | Mizuho | Buy |
| Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
Activist Altai Capital pushes for OraSure sale, board seats (update) - MSN
OraSure Technologies Sees Surge in Options Trading - National Today
OraSure Technologies Sees Unusually High Options Volume (NASDAQ:OSUR) - MarketBeat
Neil Gagnon reports 5.4% ownership in Orasure (NASDAQ: OSUR) via advisers - Stock Titan
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence - GlobeNewswire Inc.
Why OraSure Technologies, Inc. Shares Jumped - Yahoo
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
Growth Value: Why is OraSure Technologies Inc stock going up2026 Trading Volume Trends & Stepwise Trade Execution Plans - baoquankhu1.vn
OraSure Defends Strategy Amid Activist Altai Governance Challenge - The Globe and Mail
OraSure Technologies Stock Crosses Above 200-Day Moving Average - National Today
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Ideas Watch: Is OraSure Technologies Inc being accumulated by smart money2026 Selloffs & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies Inc (OSUR) Stock Price Quote Today & Current Price Chart - Capital.com
OraSure (OSUR) director receives stock grant with tax withholding on vested shares - Stock Titan
OraSure rebuts Altai, cites near-term FDA milestones, cash balance and path to cash-flow breakeven - TradingView — Track All Markets
OraSure Technologies Issues a Presentation to its Shareholders - marketscreener.com
[8-K] ORASURE TECHNOLOGIES INC Reports Material Event - Stock Titan
OSUR PE Ratio & Valuation, Is OSUR Overvalued - Intellectia AI
OraSure Technologies (OSUR) price target decreased by 11.11% to 4.08 - MSN
Trade Report: What is ONBPPs valuation compared to sector2026 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn
Vanguard disaggregates holdings; OraSure (OSUR) shows 0 shares reported - stocktitan.net
OraSure CEO Buys 32,300 Shares, Increasing Stake by 1.5% - National Today
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Insider Buying: Kenneth Mcgrath Acquires Shares of OraSure Techn - gurufocus.com
Manner Carrie Eglinton Acquires 32,300 Shares of OraSure Technologies (NASDAQ:OSUR) Stock - marketbeat.com
Insider Buying: OraSure Technologies (NASDAQ:OSUR) CFO Purchases 32,300 Shares of Stock - MarketBeat
OraSure CFO McGrath buys $94,600 in company stock By Investing.com - Investing.com Canada
OraSure (OSUR) president & CEO Eglinton buys $94,597 in shares By Investing.com - Investing.com India
OraSure (OSUR) president & CEO Eglinton buys $94,597 in shares - Investing.com UK
OraSure Technologies (OSUR) CFO adds 32,300 shares in planned buy - Stock Titan
OraSure (OSUR) CEO adds 32,300 shares in pre-planned 10b5-1 buy - Stock Titan
Altai Capital Management Reduces Stake in OraSure Technologies - GuruFocus
[Form 4] ORASURE TECHNOLOGIES INC Insider Trading Activity - Stock Titan
Activists Turn Up The Heat On Deals And Buybacks - Finimize
Sentiment Review: Is OraSure Technologies Inc attractive for institutional investors2026 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Exclusive: Altai Capital presses OraSure to sell and give it board seats, letter says - Reuters
Altai Capital presses OraSure board for overhaul, nominates two directors - MSN
Altai Calls for Strategic Review at Orasure - marketscreener.com
Investor pressures OraSure for board seats, exploration of possible sale - WFMZ.com
Altai Capital Presses OraSure Board For Overhaul, Nominates Two Directors - Benzinga
Altai Capital pushes for board seats at OraSure Technologies By Investing.com - Investing.com South Africa
Altai Capital (OSUR) builds 5.2% OraSure stake and plans proxy fight - Stock Titan
Activist Altai Capital pushes for OraSure sale, board seats (update) (OSUR:NASDAQ) - Seeking Alpha
Orasure highlights significant operational progress following letter from Altai Capital - marketscreener.com
Altai Capital (OSUR) Seeks Board Seats, Urges Strategic Review and Sale - Stock Titan
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital - The Manila Times
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter From Altai Capital - 富途牛牛
Altai Capital Pushes for OraSure (OSUR) Sale to Double Share Val - GuruFocus
Altai Capital Management Issues Letter to OraSure Board - marketscreener.com
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):